How Much Protein Do You Need on GLP-1?

Most experts now recommend approximately 1.2 to 1.6 grams of protein per kilogram of body weight per day for people losing weight on GLP-1 medications such as Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide). That is significantly higher than the standard Recommended Dietary Allowance of 0.8 g/kg/day, and the increase is driven by the need to preserve lean muscle mass during rapid weight loss.

Why does protein matter more on GLP-1 medications?

GLP-1 receptor agonists reduce appetite and slow gastric emptying, which is how they help with weight loss. But when calorie intake drops sharply, the body does not only burn fat — it also breaks down muscle for energy. In the STEP 1 trial of semaglutide 2.4 mg, lean mass loss accounted for approximately 25–40% of total weight lost, according to an exploratory body-composition analysis using DXA scans.

Similarly, body-composition data from the SURMOUNT-1 trial of tirzepatide showed that approximately 25% of total weight lost was lean mass, with fat mass making up the remaining 75%. These proportions were consistent across dose groups and subgroups.

Lean mass includes skeletal muscle, organ tissue, and bone. Losing too much of it can reduce your resting metabolic rate, weaken your bones, lower your physical strength, and make it harder to maintain weight loss long term. Adequate protein intake is one of the most important tools for limiting this loss.

How much protein should you aim for each day?

A 2025 joint advisory from four major medical organizations — the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society — recommended a protein target of 1.2 to 1.6 g/kg/day during active weight loss on GLP-1 therapy. For context, that means a person weighing 90 kg (about 200 lbs) would aim for roughly 108 to 144 grams of protein per day.

The standard RDA of 0.8 g/kg/day was designed to prevent deficiency in healthy adults at a stable weight — not for people undergoing significant caloric restriction and rapid weight change. Research on weight-loss interventions consistently shows that intakes below 1.0 g/kg/day are associated with greater muscle mass decline.

One important nuance: for individuals with a higher body weight, it is not always clear whether the protein target should be based on actual body weight, adjusted body weight, or lean body mass. Using actual body weight in someone with a BMI over 40 can overestimate needs. Your healthcare provider or a registered dietitian can help determine the right target for your situation.

What does the research say about protein and muscle preservation?

A 2025 case series examining lean tissue preservation during GLP-1 and GLP-1/GIP therapy found that patients who consumed between 1.0 and 1.7 g/kg/day of protein — and engaged in resistance training 3 to 5 days per week — were able to preserve more lean mass during weight loss compared to those with lower intake and less exercise.

A randomized controlled trial in older adults with obesity found that a protein intake of approximately 1.2 g/kg/day was the threshold needed to maintain lean body mass during caloric restriction, while those consuming the standard RDA of 0.8 g/kg/day lost significantly more muscle.

A 2025 expert consensus statement using a modified Delphi approach also emphasized that increased protein intake alone is not enough — it must be combined with structured resistance training to meaningfully preserve muscle mass. Protein without exercise, and exercise without adequate protein, are each less effective on their own.

What are the best protein sources when appetite is low?

Reduced appetite is one of the intended effects of GLP-1 medications, but it can make hitting a protein target feel difficult. When portion sizes are small, choosing protein-dense foods becomes especially important. The joint advisory recommends prioritizing nutrient-dense, minimally processed options.

Lower-volume, higher-protein foods are especially practical when you can only eat small amounts at a time. These include eggs, Greek yogurt, cottage cheese, canned fish (such as tuna or sardines), lean poultry, and nut butters like peanut or almond butter. High-protein shakes, bars, and fortified products can also help fill gaps when whole-food meals feel overwhelming.

Plant-based protein sources — beans, lentils, chickpeas, tofu, tempeh, and whole grains — contribute meaningfully to daily totals and also provide fiber, which supports digestive health. The advisory notes that red and processed meats should be consumed in moderation or minimized.

A practical tip from the Mayo Clinic's GLP-1 meal-planning guidance: eat protein-rich foods first at each meal, before vegetables and starches. When appetite is limited, this increases the chance of meeting your protein target even if you cannot finish everything on your plate.

How should you spread protein intake throughout the day?

Research on muscle protein synthesis suggests that distributing protein intake evenly across meals — rather than loading it all into one sitting — is more effective for muscle preservation. The body can only use a limited amount of protein for muscle repair at one time, so spreading intake across 3 to 4 meals and snacks helps maximize the benefit.

For someone targeting 120 grams of protein per day, that could look like 30 grams at each of four eating occasions. A practical example: two eggs and Greek yogurt at breakfast (about 30 g), a chicken breast or fish fillet at lunch (about 30 g), a protein shake or cottage cheese as a snack (about 25–30 g), and lean meat or legumes at dinner (about 30 g).

This even distribution also helps with the nausea that can occur on GLP-1 medications, since smaller, more frequent meals are generally easier to tolerate than large ones. Batch-cooking a few freezable protein-rich meals each week can help reduce the effort of meal preparation on days when appetite is especially low.

Does protein intake affect GLP-1 side effects?

Protein and fat both slow gastric emptying — which is already slowed by GLP-1 medications. In some people, very high-protein or high-fat meals can worsen constipation or feelings of fullness. A 2024 narrative review on dietary recommendations for GLP-1 patients noted that temporarily limiting high-protein or high-fat foods may be necessary during acute gastrointestinal symptoms, with a gradual return to higher protein intake as tolerance improves.

This does not mean you should avoid protein — it means pacing matters. Smaller, protein-rich meals spread throughout the day are generally better tolerated than one large high-protein meal. Liquid protein sources like shakes and smoothies may also be easier on the stomach during dose increases or periods of heightened nausea.

Should you track your protein intake on GLP-1 medications?

A 2025 cross-sectional study investigating nutrient intake during GLP-1 therapy found that many patients were not meeting recommended protein targets, often without realizing it. When appetite decreases significantly, it is easy to underestimate how little protein you are actually consuming — especially if meals become smaller and less structured.

Even rough tracking can help identify gaps. You do not need to weigh every gram, but keeping a general log of protein at each meal can reveal whether you are consistently falling short. Glone's tracking features can help you monitor protein intake alongside your medication schedule, making it easier to spot patterns over time.

If you find it consistently difficult to meet your protein target through food alone, that is worth discussing with your healthcare provider or a registered dietitian. They may recommend specific supplements, meal-replacement products, or adjustments to your eating schedule.

What about protein and hair loss on GLP-1 medications?

Inadequate protein intake during rapid weight loss is one of the factors that can contribute to telogen effluvium — the temporary hair shedding that some GLP-1 users experience. Hair is primarily made of keratin, a protein, and the hair growth cycle is sensitive to nutritional deficits.

In the STEP clinical trials, approximately 3% of patients taking Wegovy reported alopecia, with higher rates among those who lost more than 20% of body weight. While the primary trigger is the pace of weight loss rather than a single nutrient, maintaining adequate protein intake — along with iron, zinc, and vitamin D — may help reduce the risk. For a detailed look at this topic, see our guide on hair loss on semaglutide.

Does exercise change how much protein you need?

Yes. The 2025 joint advisory specifically notes that higher protein targets — closer to the 1.5–1.6 g/kg/day range — are more appropriate for individuals who are also engaging in regular resistance training. Exercise creates the stimulus for muscle repair and growth, but without sufficient protein as building material, the repair process is impaired.

A 2025 review on preserving lean mass during GLP-1 therapy found that the combination of high protein intake and structured exercise produced the greatest benefit for bone and muscle preservation — more than either strategy alone. Resistance training 2 to 4 times per week, targeting major muscle groups, is the most commonly recommended approach.

If you are not currently exercising, your protein needs may be slightly lower (closer to 1.2 g/kg/day), but they are still well above the standard RDA. Talk to your healthcare provider before starting a new exercise program, especially during the early phases of GLP-1 treatment when energy levels and appetite may be fluctuating.

Sources

• Nutritional Priorities to Support GLP-1 Therapy for Obesity — Joint Advisory (2025) — pmc.ncbi.nlm.nih.gov
• Preservation of Lean Soft Tissue During Weight Loss Induced by GLP-1 and GLP-1/GIP Receptor Agonists (2025) — pmc.ncbi.nlm.nih.gov
• Body Composition Changes During Weight Reduction with Tirzepatide in SURMOUNT-1 (2025) — pmc.ncbi.nlm.nih.gov
• Impact of Semaglutide on Body Composition in Adults: Exploratory Analysis of STEP 1 (2021) — pmc.ncbi.nlm.nih.gov
• Nutritional and Lifestyle Supportive Care Recommendations for GLP-1 Therapies — Expert Consensus (2025) — sciencedirect.com
• Investigating Nutrient Intake During Use of GLP-1 Receptor Agonists (2025) — pmc.ncbi.nlm.nih.gov
• Dietary Recommendations for GI Symptoms in Patients on GLP-1 Receptor Agonists (2024) — pmc.ncbi.nlm.nih.gov
• Preserving Healthy Muscle During Weight Loss — pmc.ncbi.nlm.nih.gov